Clinical trial · Observational
Monocentric Retrospective and Prospective Observational Study of Patients With Colorectal Cancer
NCT07663162CI-TRIAL-00115507CRC-Rnot yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Monocentric retrospective and prospective observational study of patients with colorectal cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CRC (Colorectal Cancer) | Colorectal Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients affected by colorectal neoplasm (regardless of disease stage)
- description
- Inclusion Criteria 1. Participant is willing and able to give informed and written consent for the participation in the study 2. Patients affected by colorectal neoplasm (regardless of disease stage) 3. Aged \> 18 years 4. Patients in clinical conditions permissive to adhere to the diagnostic-therapeutic program proposed in according to the stage of the disease Exclusion Criteria 1. Pediatric population 2. Pre-existing conditions or concurrent diagnoses that would preclude the participant's full adherence with or completion of the study 3. Pregnancy
Primary outcomes (5)
- measure
- Overall Survival (OS)
- timeFrame
- From date of diagnosis until the date of death from any cause or last follow up, assessed up to 5 years
- description
- Overall survival, defined as the time from diagnosis to death from any cause.
- measure
- Progression-Free Survival (PFS)
- timeFrame
- From date of start of each treatment line until the date of first documented progression or date of death from any cause, assessed up to 12 months. Tumor assessments will be performed in accordance with clinical practice.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Participant is willing and able to give informed and written consent for the participation in the study 2. Patients affected by colorectal neoplasm (regardless of disease stage) 3. Aged \> 18 years 4. Patients in clinical conditions permissive to adhere to the diagnostic-therapeutic program proposed in according to the stage of the disease Exclusion Criteria: 1. Pediatric population 2. Pre-existing conditions or concurrent diagnoses that would preclude the participant's full adherence with or completion of the study 3. Pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.